• Disease Overview
  • Synonyms
  • Signs & Symptoms
  • Causes
  • Affected Populations
  • Disorders with Similar Symptoms
  • Standard Therapies
  • Clinical Trials and Studies
  • References
  • Programs & Resources
  • Complete Report
Select language / seleccionar idioma:

Cleidocranial Dysplasia

Print

Last updated: 03/23/2023
Years published: 1993, 1995, 1996, 2003, 2004, 2023


Acknowledgment

NORD gratefully acknowledges Caitlin Caporale, MSGDA Candidate, NORD Editorial Intern from the Keck Graduate Institute School of Pharmacy and Health Sciences and Stacey McIlroy, MMS, PA-C, Principal Faculty in the Master of Science in the Physician Assistant Studies program at Keck Graduate Institute for assistance in the preparation of this report.


Disease Overview

Cleidocranial dysplasia is a rare genetic disorder characterized by abnormal bone formation commonly affecting the skull, teeth and long bones. As a result, short stature, distinctive facial features and narrow, sloping shoulders caused by abnormally developed or absent collarbones (clavicles) may be present in affected individuals. Major features may include premature closing of the soft spot on the head (coronal), delayed closure of the space between the bones of the skull (fontanels), narrow and abnormally shaped pelvic and pubic bones and abnormalities in development of the chest (thoracic region). If not diagnosed at birth, clinical presentation of remarkable features may be most notable in early childhood or adolescence. Additionally, a high arched palate, failure of the lower jaw joints to unite, delayed eruption of teeth and fingers that are irregular in length may also be present. Cleidocranial dysplasia is inherited as an autosomal dominant genetic condition. Approximately 1,000 cases of this disorder have been reported in the medical literature.

  • Next section >
  • < Previous section
  • Next section >

Synonyms

  • cleidocranial dysostosis
  • dysplasia, cleidocranial
  • cysplasia, osteodental
  • Marie-Sainton Disease
  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Signs & Symptoms

Because affected individuals can present with an array of features related to cleidocranial dysplasia, it is not always diagnosed at birth. The most prominent feature of cleidocranial dysplasia is the absence of collarbones or narrow, drooping shoulders caused by complete or partial absence of the collarbones. There may be abnormalities of the muscles in the area of the collarbones associated with an irregularly wide range of shoulder movement in affected individuals with collarbone abnormalities. Another prominent feature is atypical skull formation or skull abnormalities, which may include a premature closure of the two soft spots on the head (fontanels) and the fibrous joints where bones of the skull meet (sutures) causing abnormal development of the skull. Distinct facial features typically include a prominent forehead, unusually wide face, prominent chin, small upper jaw (maxillary hypoplasia) and bulging of the skull cap. Most individuals with cleidocranial dysplasia have some but not necessarily all features listed above and are diagnosed between birth and adolescence as the child develops and abnormalities may become more noticeable over time (irregular growth of long bones or pelvis, atypical facial feature development, abnormal tooth or jaw formation, etc.).

Other bone abnormalities that have been found in some patients with cleidocranial dysplasia may be: a wide pelvic joint, delayed growth of the pubic bone, a hip defect in which the thigh bone angles towards the center of the body (coxa vara), failure of the lower jaw bones to unite, a defect of the hip that causes the thigh bone to angle out to the side of the body (coxa valga), curvature of the spine (scoliosis), a small shoulder blade and/or curvature of the upper legs so that the knees appear unusually close together (genu valgum).

Dental abnormalities may include: a delay in tooth eruption, incomplete development or absence of teeth, underdeveloped enamel and/or extra teeth. Cysts may form around the unerupted or displaced teeth in some people. A high-arch palate or a condition in which there is a hole in the roof of the mouth (cleft palate) may be present.

Individuals with cleidocranial dysplasia have an increased risk for recurrent ear and sinus infections, upper respiratory complications and hearing loss.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Causes

Cleidocranial dysplasia is caused by changes (mutations or pathogenic variants) in the RUNX2 gene (originally called the CBFA1 gene). This gene codes for a protein that affects bone development and the proliferation of healthy osteoblasts. Osteoblasts are the specific cell type that make up bones and contribute to proper bone formation in the body. RUNX2 is a transcription factor or regulator of osteoblast generation in the body termed osteogenesis. About 20-30% of individuals with cleidocranial dysplasia do not have a pathogenic variant in the RUNX2 gene. This suggests that there are other genetic causes of this condition.

Cleidocranial dysplasia is a rare disorder that is usually inherited as an autosomal dominant genetic condition. Dominant genetic disorders occur when only a single copy of a non-working gene is necessary to cause a particular disease. The non-working gene can be inherited from either parent or can be the result of a changed (mutated) gene in the affected individual. The risk of passing the non-working gene from an affected parent to an offspring is 50% for each pregnancy. The risk is the same for males and females.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Affected populations

Cleidocranial dysplasia is a very rare disorder that is apparent at birth and affects males and females in equal numbers. Approximately 1,000 cases of this disorder have been reported in the medical literature. The birth prevalence is approximately 1 in 1 million.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Standard Therapies

Treatment

There is no cure for cleidocranial dysplasia. However, certain symptoms and features may be treated as they become apparent. Head gear in the form of a baby helmet may be worn after birth to protect the skull bones until they close. If dental abnormalities are present, appropriate dental care should be provided such as attending to tooth deformation or mandibular abnormalities possibly with surgical intervention. If a cleft palate is present, surgery may also be performed to close or block the opening to improve quality of life. Hearing evaluations should be performed at birth and throughout childhood since hearing complications may be present in individuals with cleidocranial dysplasia.

Affected individuals have an increased risk for sleep apnea, sinus infections and ear infections due to delayed craniofacial development and should be assessed for symptoms that may require treatment as needed. Overall bone density should also be monitored over time and treatment provided if indicated. Speech and language may need to be assessed by a speech pathologist.

Genetic counseling is recommended for patients and their families. Other treatments are dependent on symptoms and supportive as needed due to the variety of effects this condition can have on the body as mentioned above.

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

Clinical Trials and Studies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: prpl@cc.nih.gov

Some current clinical trials also are posted on the following page on the NORD website: https://rarediseases.org/for-patients-and-families/information-resources/info-clinical-trials-and-research-studies/

For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com

For information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/

  • < Previous section
  • Next section >
  • < Previous section
  • Next section >

References

TEXTBOOKS

Golan I, Baumert U, and Muessig D. Cleidocranial Dysplasia. In: The NORD Guide to Rare Disorders, Philadelphia: Lippincott, Williams and Wilkins, 2003: 182-3.

JOURNAL ARTICLES

Liu D, Liu Y, Zhang X, Wang Y, Zhang C, Zheng S. An exploration of mutagenesis in a family with cleidocranial dysplasia without RUNX2 mutation. Front Genet. 2021;12:748111. Published 2021 Oct 19. doi:10.3389/fgene.2021.748111

Golan I, Preising M, Wagner H, et al. A novel missense mutation of the CBFA1 gene in a family with cleidocranial dysplasia (CCD) and variable expressivity. J Craniofac Genet Dev Biol. 2000;20:113-120.

Gao X, Li K, Fan Y, et al. Identification of RUNX2 variants associated with cleidocranial dysplasia. Hereditas. 2019;156:31. Published 2019 Sep 16. doi:10.1186/s41065-019-0107-7

Mundlos S. Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet. 1999;36:177-182.

Becker A, Lustmann J, Shteyer A. Cleidocranial dysplasia: part 1-general principles of the orthodontic and surgical treatment modality. Am J Orthod Dentofac Orthop. 1997;11:28-33.

INTERNET

McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). Baltimore MD: The Johns Hopkins University Press; Entry No. 119600; Last Update: 10/28/2022. https://www.omim.org/entry/119600 Accessed Jan 25, 2023.

  • < Previous section
  • Next section >

Programs & Resources

RareCare® Assistance Programs

NORD strives to open new assistance programs as funding allows. If we don’t have a program for you now, please continue to check back with us.

Additional Assistance Programs

MedicAlert Assistance Program

NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.

Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/

Rare Disease Educational Support Program

Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORD’s mission.

Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/

Rare Caregiver Respite Program

This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.

Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/

Patient Organizations


National Organization for Rare Disorders